AU Patent

AU2013219211B2 — Nicotine lozenge compositions

Assigned to North Star Opco Ltd · Expires 2016-05-12 · 10y expired

What this patent protects

Docmnt8-22/08/2013 The present invention relates to nicotine lozenge compositions comprising reduced levels of buffering agents from traditional nicotine lozenges and which provide optimal oral pH and prompt nicotine absorption in a smaller, more convenient dosage form.

USPTO Abstract

Docmnt8-22/08/2013 The present invention relates to nicotine lozenge compositions comprising reduced levels of buffering agents from traditional nicotine lozenges and which provide optimal oral pH and prompt nicotine absorption in a smaller, more convenient dosage form.

Drugs covered by this patent

Patent Metadata

Patent number
AU2013219211B2
Jurisdiction
AU
Classification
—
Expires
2016-05-12
Drug substance claim
No
Drug product claim
No
Assignee
North Star Opco Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.